-
IOVA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Iovance Biotherapeutics (IOVA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 170.54 mm | 170.54 mm | 170.54 mm | 170.54 mm | 170.54 mm | 170.54 mm |
Cash burn (monthly) | 21.52 mm | 13.63 mm | 29.69 mm | 35.83 mm | 19.66 mm | 30.30 mm |
Cash used (since last report) | 88.30 mm | 55.93 mm | 121.80 mm | 146.99 mm | 80.65 mm | 124.33 mm |
Cash remaining | 82.24 mm | 114.61 mm | 48.74 mm | 23.55 mm | 89.89 mm | 46.22 mm |
Runway (months of cash) | 3.8 | 8.4 | 1.6 | 0.7 | 4.6 | 1.5 |
13F holders | Current |
---|---|
Total holders | 287 |
Opened positions | 43 |
Closed positions | 52 |
Increased positions | 106 |
Reduced positions | 83 |
13F shares | Current |
---|---|
Total value | 2.08 tn |
Total shares | 264.46 mm |
Total puts | 1.68 mm |
Total calls | 3.77 mm |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Quogue Capital | 30.00 mm | $360.90 mm |
Vanguard | 27.31 mm | $256.48 bn |
Perceptive Advisors | 26.62 mm | $249.94 bn |
MHR Fund Management | 24.00 mm | $225.33 bn |
BlackRock | 21.48 mm | $201.73 bn |
STT State Street | 13.20 mm | $123.97 bn |
Soleus Capital Management | 8.53 mm | $80.08 bn |
Hood River Capital Management | 8.14 mm | $76.48 bn |
T. Rowe Price Investment Management | 5.86 mm | $55.04 mm |
Geode Capital Management | 5.65 mm | $53.05 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jan 25 | Bilinsky Igor | Common Stock | Payment of exercise | Dispose F | No | No | 5.89 | 1,578 | 9.29 k | 58,774 |
14 Jan 25 | Bilinsky Igor | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,813 | 0.00 | 60,352 |
14 Jan 25 | Bilinsky Igor | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 2,813 | 0.00 | 0 |
14 Jan 25 | Frederick G Vogt | Common Stock | Payment of exercise | Dispose F | No | No | 5.89 | 9,955 | 58.63 k | 221,116 |
14 Jan 25 | Frederick G Vogt | Common Stock | Option exercise | Acquire M | No | No | 0 | 20,835 | 0.00 | 231,071 |
14 Jan 25 | Frederick G Vogt | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 20,835 | 0.00 | 0 |
14 Jan 25 | Finckenstein Friedrich Graf | Common Stock | Payment of exercise | Dispose F | No | No | 5.89 | 1,578 | 9.29 k | 63,886 |
14 Jan 25 | Finckenstein Friedrich Graf | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,813 | 0.00 | 65,464 |
14 Jan 25 | Finckenstein Friedrich Graf | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 2,813 | 0.00 | 0 |
16 Dec 24 | Raj K. Puri | Common Stock | Payment of exercise | Dispose F | No | No | 7.84 | 3,759 | 29.47 k | 155,412 |